G. Dover

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors.

R. Fram, D. A. Echo, Edward A. Sausville, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I Study of the Orally Administered Butyrate Prodrug, Tributyrin, in Patients with Solid Tumors1

E. Sausville, B. Conley, M. Egorin, 2022 .